Charles Schwab’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,336
| Closed | -$49K | – | 3504 |
|
|
2024
Q3 | $49K | Hold |
6,336
| – | – | ﹤0.01% | 3415 |
|
|
2024
Q2 | $38K | Sell |
6,336
-16,313
| -72% | -$97.9K | ﹤0.01% | 3539 |
|
|
2024
Q1 | $204K | Hold |
22,649
| – | – | ﹤0.01% | 3240 |
|
|
2023
Q4 | $215K | Sell |
22,649
-11,895
| -34% | -$113K | ﹤0.01% | 3267 |
|
|
2023
Q3 | $411K | Buy |
34,544
+15,957
| +86% | +$190K | ﹤0.01% | 3113 |
|
|
2023
Q2 | $455K | Buy |
18,587
+4,356
| +31% | +$107K | ﹤0.01% | 3100 |
|
|
2023
Q1 | $445K | Buy |
14,231
+216
| +2% | +$6.76K | ﹤0.01% | 2986 |
|
|
2022
Q4 | $987K | Buy |
14,015
+161
| +1% | +$11.3K | ﹤0.01% | 2776 |
|
|
2022
Q3 | $1.19M | Buy |
13,854
+1,965
| +17% | +$169K | ﹤0.01% | 2729 |
|
|
2022
Q2 | $984K | Buy |
11,889
+1,777
| +18% | +$147K | ﹤0.01% | 2805 |
|
|
2022
Q1 | $1.68M | Buy |
10,112
+1,172
| +13% | +$195K | ﹤0.01% | 2707 |
|
|
2021
Q4 | $1.5M | Buy |
8,940
+429
| +5% | +$71.7K | ﹤0.01% | 2783 |
|
|
2021
Q3 | $736K | Sell |
8,511
-490
| -5% | -$42.4K | ﹤0.01% | 2995 |
|
|
2021
Q2 | $489K | Buy |
9,001
+1,369
| +18% | +$74.4K | ﹤0.01% | 3171 |
|
|
2021
Q1 | $455K | Buy |
7,632
+32
| +0.4% | +$1.91K | ﹤0.01% | 3111 |
|
|
2020
Q4 | $397K | Hold |
7,600
| – | – | ﹤0.01% | 3062 |
|
|
2020
Q3 | $368K | Buy |
7,600
+923
| +14% | +$44.7K | ﹤0.01% | 2966 |
|
|
2020
Q2 | $346K | Sell |
6,677
-1,009
| -13% | -$52.3K | ﹤0.01% | 2978 |
|
|
2020
Q1 | $336K | Buy |
7,686
+4,180
| +119% | +$183K | ﹤0.01% | 2841 |
|
|
2019
Q4 | $141K | Hold |
3,506
| – | – | ﹤0.01% | 3076 |
|
|
2019
Q3 | $115K | Hold |
3,506
| – | – | ﹤0.01% | 3086 |
|
|
2019
Q2 | $271K | Buy |
3,506
+686
| +24% | +$53K | ﹤0.01% | 3042 |
|
|
2019
Q1 | $501K | Buy |
2,820
+1,571
| +126% | +$279K | ﹤0.01% | 2768 |
|
|
2018
Q4 | $295K | Buy |
1,249
+272
| +28% | +$64.2K | ﹤0.01% | 2941 |
|
|
2018
Q3 | $210K | Buy |
+977
| New | +$210K | ﹤0.01% | 3069 |
|